Session IV
Tel Aviv, Israel, 11-May-23
![]() | New horizon about glycemic management and CVD: GLP-1 + GIP, GLP-1 + Glucagon, GLP-1+ GIP + Glucagon, GLP1+ Amylin Giorgino, Prof. F. |
![]() | New ESC Guidelines and 2022 ADA Consensus for the diagnosis and treatment of heart failure- key points Schnell, Prof. O. |
![]() | New treatment approaches for CKD with a cardiovascular benefit-Key points Wanner, Prof. C. |
![]() | The fatty Liver – a game changer in D& CVD? Lalic, Prof. N. |